ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

Hammer Agrees To Bush Request for FDA Probe

July 15, 1988

Six Years into The Drug Shortage, And The Causes Are Still a Mystery

October 14, 2011

NCCS Selects New President

October 9, 2009

Radiation To Stem Cell Niche Improved PFS In Glioblastoma

August 27, 2010